As we all know, zongzi is a high GI (glycemic index) food, so many sugar friends are in trouble——

Eat, and worry about blood sugar spikes;

If I don't eat, I'm so thirsty, I feel like there's no festiv.

To eat or not to eat, that is the questi.

Can diabetics eat dumplings?

Although Zongzi is a high GI food, it does not mean that sugar lovers can't touch it at a.

If blood sugar is well controlled, and there is no serious diabetic gastrointestinal disorder or other gastrointestinal diseases, it can be eaten in moderati.

What counts as good blood sugar control?

The key to look at these 4 points:

① Fasting blood glucose <7mmol/L;

②Non-fasting blood glucose <10mmol/L;

③Glycated hemoglobin <7%;

④ The blood sugar has remained relatively stable recently, and there is no fluctuation of high and l.

Master 3 tips, eat zongzi without raising blood sugar

Control the total intake

After eating zongzi, you need to eat less or no other staple foods accordingly, such as rice, noodles, sweet potatoes, potatoes, e.

It is best to choose rice dumplings, such as red bean dumplings, eight-treasure dumplings, or dumplings with buckwheat and oatmeal added, which can delay the rise in blood sug.

It is best to eat rice dumplings not more than 100g a day, and you should chew and swallow slowly when eati.

After eating, check blood sugar in time

After eating zongzi, don't lie down or sit immediate.

It is recommended to measure blood sugar before and after eating zongzi, so as to understand the changes in blood sugar after eating zong.

Don’t forget to take hypoglycemic drugs

When family and friends get together during the holidays, many sugar friends may forget to take their medici.

As everyone knows, this is very dangerous! "Drug therapy" is the key to stabilizing blood sugar and the condition of diabetic patien.

Therefore, sugar friends can't just focus on being happy during the festiv.

When it comes to taking medicine, many people with diabetes will have a headache: So many hypoglycemic drugs, which one should I take?

Always keep this "guanidine" at home, grasp blood sugar and zongzi with both hands

There is a hypoglycemic drug, although there are constantly new drugs on the market "debuting", it has never been able to shake its "C position" stat.

It is the famous hypoglycemic brother - " Metformin "!

As a "senior" hypoglycemic drug, metformin has always been the first choice drug recommended by authoritative diabetes guidelines at home and abro.

The "Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition)" expressly recommends that metformin drug therapy is the first-line treatment for patients with type 2 diabetes, and it is also the cornerstone of combination therapy; if there is no contraindication, metformin should be kept in the drug treatment of diabet.

Program [

The 2020 American Diabetes Association (ADA) guidelines recommend that metformin be the first-line drug throughout the entire treatment of diabetes [

Why can "metformin" stand out from many hypoglycemic drugs and become the first-line drug of choice for the treatment of type 2 diabetes?

Because its own strength is "hard enough"!

Hundred years of history, experienced the test of the century

With the research and development of medicines, many old medicines will be replaced by later new medicines and disappear in the long river of histo.

Metformin has withstood the test of ti.

It has been 100 years since its first synthesis, and it has been clinically used for 65 yea.

No matter how many new drugs appear, it still stands out, and its status in the hypoglycemic field is irreplaceable [3].

High safety, lifelong use will not hurt the body

As the saying goes, "drugs are three parts of poiso.

As a chronic disease, diabetes requires lifelong medicati.

Diabetics will inevitably worry about whether taking medicine every day will harm the body and is bad for the liver and kidneys?

rest assured! Metformin is an old antidiabetic drug, and its safety is time-prov.

After metformin enters the human body, it is absorbed into the blood through the intestinal tract, and then distributed to all parts of the body to complete the hypoglycemic missi.

This process is not metabolized by the liver, so there is no hepatotoxici.

When excreted, it is mainly excreted from the urine through the renal tubule in the prototype, and it is quickly cleared, so it will not harm the kidneys [
However, diabetic patients with liver and kidney insufficiency need to take medicine under the professional guidance of a doct.

Two dosage forms are commonly used to meet the needs of different sugar lovers

There are two commonly used dosage forms of metformin, namely ordinary tablets and sustained-release table.

Sugar lovers can choose the medicine according to their own conditio.

Taking the original research metformin as an example, the two dosage forms have their own advantag.

Sugar friends can choose the dosage form that suits them according to the doctor's advice and their own circumstanc.

Original Metformin Ordinary Tablets

The original metformin ordinary tablet is cost-effective, and even if it is taken for life, it will not bring too much economic burden to the patie.

In addition, there are 60 original metformin ordinary tablets in a large package, which can be eaten for a while, which can effectively alleviate the inconvenience of frequent drug purchases, and there is no need to worry about stopping the drug during the epidem.

However, it has two minor drawbacks:

First, after taking it, the drug will be rapidly dissolved and released in the stomach, which may easily cause gastrointestinal adverse reactions such as nausea, vomiting, and diarrhea; second, it needs to be taken multiple times, 2 to 3 times a day, which is easy to mi.

Original Metformin Sustained Release Tablets

The original metformin sustained-release tablet can be said to be an "upgraded version" of ordinary table.

Compared with ordinary tablets, it has two obvious advantages:

▶ Small gastrointestinal side effects

The original metformin sustained-release tablet is a pharmaceutical dosage form prepared by slow and controlled technolo.

After taking it, it dissolves and releases slowly in the gastrointestinal tra.

It can effectively reduce blood sugar and reduce gastrointestinal adverse reactions [

△ A retrospective study in the United States using the original metformin extended-release tablet as the treatment drug showed that the initial use of the original metformin extended-release tablet can reduce the incidence of gastrointestinal adverse events by 50% and the incidence of diarrhea events by 75% [

In 2020, the original research metformin sustained-release tablet was listed on the "2019-2020 Family Standing Drug List" jointly organized by Family Doctor Online, "Pharmaceutical Economic News" and other institutions, and won unanimous praise from sugar frien.

▶ It only needs to be taken once a day, which can improve the patient's medication compliance

After the sustained-release tablet enters the gastrointestinal tract orally, it can continuously release a quantitative drug to maintain the efficacy of the dr.

It only needs to be taken once a day to achieve a slow-release and stable hypoglycemic effect [

Compared with ordinary tablets, sustained-release tablets once a day have better gastrointestinal tolerance and can improve patients' medication compliance [

Studies have shown that the compliance of the original metformin sustained-release tablets is as high as 96% [

It is very suitable for diabetic patients who are very busy at work or have poor memory and take many types of medicines, which can avoid the phenomenon of missing medicin.

In short, as long as diabetic patients can control their blood sugar well, take medicine on time every day, and mix their meals reasonably, they can also spend a healthy and happy Dragon Boat Festiv.

Edit: Mumu

Drawing: Liaoqin

Produced by: "Chinese Family Doctor" magazine

Academic Advisor: Wei Guohong

Deputy Chief Physician, Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University

Deputy Head of the Diabetic Foot Professional Group of the Endocrinologist Branch of the Guangdong Medical Doctor Association

Engaged in clinical work in endocrine and metabolic diseases for more than 20 years

Undertake undergraduate, adult undergraduate and nursing professional theory courses, trainee, practice teaching, and has been awarded the title of "excellent teacher" by the hospital for many tim.

Presided over 2 provincial and ministerial-level funds, participated in many national and provincial-level funds, and published many papers, including 5 SCI papers by the first/newsletter (including tie-in) authors

references

[1] Diabetes Society of Chinese Medical Associati.

Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 Editio.

Chinese Journal of Practical Internal Medicine, 2021, 8(8): 676-67

[2] oyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo.

Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideli.

Ann Intern Med, 2020 Sep

[3] Lu Jumi.

The historical status of metformin in the prevention and treatment of type 2 diabet.

Chinese Journal of Diabetes, 2011, 3(2): 3-

[4] Yiming Mu, Linong Ji, et .

Expert consensus on clinical application of metformin (2018 editio.

Chinese Journal of Diabetes, 2019, 27(3): 161-17

[5] Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills .

Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort stu.

Current medical research and opini.

2004; 20 (4): 565-57

[6] https://vi.

ine.

.

com/a/20211229A04FKU00

[7] Hu Aimin, Xu Naij.

Metformin: 3 dosage forms, 3 points of attenti.

Family Medici.

2015, 07: 42

[8] Mu Yiming, Ji Linong, Ning Guang, et .

Expert consensus on clinical application of metformin (2016 edition) [.

Chinese Journal of Diabetes, 2016, 24(10): 871-88

[9] Ji L, Liu J, Yang J, et .

Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT tri.

Diabetes Obes Metab, 2018, 20(4): 1006-101